CODAGENIX INC.

Profile

Company Names

CODAGENIX INC.

Addresses

3 BIOSCIENCE PARK DR., FARMINGDALE, NY 11735

Phone Numbers

631-227-3932

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$25,005,232.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-02-10 
$25,005,232.00 
$25,005,232.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
ROBERT 
COLEMAN 
EXECUTIVE OFFICER, DIRECTOR
CODAGENIX INC.
TYLER 
 
COOK 
EXECUTIVE OFFICER
CODAGENIX INC.
PAUL 
 
GRINT 
DIRECTOR
NUMIRA BIOSCIENCES INC   |  SYNEDGEN, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  CARDEA BIO, INC.   |  CODAGENIX INC.   |  CRISPRQC INC.   |  INHIBIKASE THERAPEUTICS, INC.
JILL 
 
HOWE 
DIRECTOR
GOSSAMER BIO, INC.   |  CODAGENIX INC.
STEFFEN 
 
MUELLER 
DIRECTOR
CODAGENIX INC.
CHARLIE 
 
PETTY 
DIRECTOR
CODAGENIX INC.   |  GLOBAL HEALTH SECURITY FUND, L.P.
GLENN 
 
ROCKMAN 
DIRECTOR
IANTECH, INC.   |  INDEVR, INC.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.   |  CODAGENIX INC.   |  VITRIVAX, INC.
LORI 
 
RUDOLPH-OWEN 
DIRECTOR
GOLDFINCH BIO, INC.   |  CODAGENIX INC.
STEVEN 
 
WINICK 
DIRECTOR
MIRIMUS, INC.   |  CELMATIX INC.   |  SETPOINT MEDICAL CORP   |  CODAGENIX INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-02-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#